n. a monoamine oxidase inhibitor developed in the 1950s for the treatment of tuberculosis and later found to have therapeutic value in the treatment of mood disorders. Iproniazid was found to elevate the mood of tuberculosis patients, and clinical trials led to its widespread use as an antidepressant. However, it has now been replaced by other less toxic antidepressant drugs.